Exagen Inc. Profile Avatar - Palmy Investing

Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosi…

Medical - Diagnostics & Research
US, Vista [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Exagen Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Exagen Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Exagen Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of XGN's Analysis
CIK: 1274737 CUSIP: 30068X103 ISIN: US30068X1037 LEI: - UEI: -
Secondary Listings
XGN has no secondary listings inside our databases.